We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
Cap. Flow
+$505M
Cap. Flow %
0.65%
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$83.5M
2
SPGI icon
S&P Global
SPGI
+$73.5M
3
TSLA icon
Tesla
TSLA
+$55.8M
4
MSFT icon
Microsoft
MSFT
+$45.9M
5
AMZN icon
Amazon
AMZN
+$27.9M

Top Sells

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$88.8M
2
INFO
IHS Markit Ltd. Common Shares
INFO
+$74.7M
3
CONE
CyrusOne Inc Common Stock
CONE
+$31.7M
4
ABT icon
Abbott
ABT
+$25.5M
5
EXC icon
Exelon
EXC
+$23.2M

Sector Composition

Rank Sector Weight
1 Technology 24.74%
2 Financials 13.53%
3 Healthcare 13.01%
4 Consumer Discretionary 11.66%
5 Industrials 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYT
2976
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$47K ﹤0.01%
+12,555
New +$71.5K
GTBP icon
2977
GT Biopharma
GTBP
$11.5M
$46K ﹤0.01%
536
-20
-4% -$1.76K
FOA icon
2978
Finance of America Companies
FOA
$198M
$45K ﹤0.01%
1,485
-772
-34% -$26.9K
BYSI icon
2979
BeyondSpring
BYSI
$35.8M
$44K ﹤0.01%
20,091
+4,457
+29% +$12.9K
ETNB
2980
DELISTED
89bio
ETNB
$42K ﹤0.01%
+11,173
New +$72K
LVO icon
2981
LiveOne
LVO
$58.2M
$40K ﹤0.01%
4,952
-33
-0.7% -$288
ALGS icon
2982
Aligos Therapeutics
ALGS
$34.9M
$37K ﹤0.01%
681
+155
+29% +$12.4K
APLT
2983
DELISTED
Applied Therapeutics
APLT
$37K ﹤0.01%
17,409
-706
-4% -$1.89K
SMMT icon
2984
Summit Therapeutics
SMMT
$11.1B
$37K ﹤0.01%
15,115
+2,292
+18% +$5.78K
FTH
2985
Faeth Therapeutics
FTH
$629M
$37K ﹤0.01%
808
-137
-14% -$10.9K
AVTX icon
2986
Avalo Therapeutics
AVTX
$983M
$36K ﹤0.01%
17
+1
+6% +$2.51K
LFWD icon
2987
ReWalk Robotics
LFWD
$21.6M
$36K ﹤0.01%
368
– –
ADN
2988
DELISTED
Advent Technologies
ADN
$35K ﹤0.01%
503
+124
+33% +$14K
ONCR
2989
DELISTED
Oncorus, Inc.
ONCR
$35K ﹤0.01%
19,535
-2,656
-12% -$7.44K
HOOK
2990
DELISTED
HOOKIPA Pharma
HOOK
$32K ﹤0.01%
1,412
-62
-4% -$1.11K
HYRE
2991
DELISTED
HyreCar Inc. Common Stock
HYRE
$32K ﹤0.01%
13,507
+3,006
+29% +$9.29K
RFL icon
2992
Rafael Holdings
RFL
$107M
$29K ﹤0.01%
11,750
+530
+5% +$1.82K
KLDO
2993
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$29K ﹤0.01%
17,394
+1,201
+7% +$2.14K
SHCR
2994
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$28K ﹤0.01%
11,337
– –
BLRX
2995
BioLineRX
BLRX
$11.8M
$25K ﹤0.01%
364
– –
ELTX icon
2996
Elicio Therapeutics
ELTX
$83.8M
$25K ﹤0.01%
1,170
+75
+7% +$1.69K
HIPO icon
2997
Hippo Holdings
HIPO
$861M
$25K ﹤0.01%
494
– –
IRON icon
2998
Disc Medicine
IRON
$2.97B
$24K ﹤0.01%
577
-48
-8% -$2.52K
AFIB
2999
DELISTED
Acutus Medical Inc
AFIB
$17K ﹤0.01%
12,238
+1,048
+9% +$2.24K
TLIS
3000
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$16K ﹤0.01%
760
-79
-9% -$2.73K
118 119
120
121 122

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
  • RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
  • RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
  • RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
  • RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
  • RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.

Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.